v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS    
Cash and cash equivalents $ 2,189,232 $ 468,998
Inventory, net 12,807 13,689
Prepaid expenses and other current assets 124,779 44,794
TOTAL CURRENT ASSETS 2,326,818 527,481
NON-CURRENT ASSETS    
Intellectual property, net, a related party 2,850,000
Investment in NovoDX, a related party 500,000
TOTAL NON-CURRENT ASSETS 3,350,000
TOTAL ASSETS 2,326,818 3,877,481
CURRENT LIABILITIES    
Accounts payable 170,351 169,432
Accrued expenses and other current liabilities 6,493 16,673
TOTAL CURRENT LIABILITIES 176,844 186,105
Long-term debt, net 58,650
TOTAL NON CURRENT LIABILITIES 58,650
TOTAL LIABILITIES 235,494 186,105
COMMITMENTS AND CONTINGENCIES (Note 7)
STOCKHOLDERS’ EQUITY    
Preferred stock, par value of $0.001 per share; 1,000,000 shares authorized, no shares issued and outstanding
Common stock, par value of $0.001 per share; 100,000,000 shares authorized as of December 31, 2025 and 2024; 14,761,925, and 13,110,000 shares issued and outstanding as of December 31, 2025 and 2024, respectively 14,762 13,110
Additional paid-in capital 9,135,341 4,541,057
Common stock payable 83,003
Subscription receivable (800)
Accumulated deficit (7,140,982) (862,791)
TOTAL STOCKHOLDERS’ EQUITY 2,091,324 3,691,376
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 2,326,818 $ 3,877,481